Li Q, Shao S, Zhu Z, Chen J, Hao J, Bai Y, Li B, Dang E, Wang G
Some clinicians favor TB-500 for patients who want fewer injections per week thats a real quality-of-life consideration over a 4 to 12 week cycle
Semaglutide and tirzepatide have FDA-approved uses under certain brand names and indications
Measures including PSA density, free PSA, rectal examination, and transrectal ultrasonography may help determine whether a PSA increase is due to BPH or prostate cancer
Protective effect of naringenin on glutamate-induced neurotoxicity in cultured hippocampal cells
Patients hold overwhelming demand for GLP-1s, but access (supply + list price cost) creates constraints Employers and payors are grappling with benefit design and coverage access qualifications for GLP-1s (e.g., limiting to diabetes patients)